Mesco Pharmaceuticals Ltd.
| BSE: 500274 | Sector: Health care |
| NSE: MESCOPHARM | ISIN Code: INE839X01015 |
| BSE 00:00 | 10 Jan | Mesco Pharmaceuticals Ltd |
| NSE 05:30 | 01 Jan | Mesco Pharmaceuticals Ltd |
| OPEN | 4.54 |
| PREVIOUS CLOSE | 4.54 |
| VOLUME | 700 |
| 52-Week high | 5.69 |
| 52-Week low | 3.61 |
| P/E | |
| Mkt Cap.(Rs cr) | 9 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Mesco Pharmaceuticals Ltd. (MESCOPHARM) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 541.95 | -16.90 | -3.02 | 15823.68 |
| Cipla | 969.90 | -0.65 | -0.07 | 13900.58 |
| Dr Reddy's Labs | 4335.10 | 60.85 | 1.42 | 13349.10 |
| Sun Pharma.Inds. | 922.00 | 0.55 | 0.06 | 12803.21 |
| Lupin | 609.10 | -9.30 | -1.50 | 11055.93 |
| Apollo Hospitals | 3655.80 | -65.75 | -1.77 | 9153.00 |
| Zydus Lifesci. | 370.05 | 7.65 | 2.11 | 7790.40 |
| Glenmark Pharma. | 395.05 | -8.35 | -2.07 | 7567.93 |
| Alkem Lab | 2956.75 | -28.30 | -0.95 | 7219.68 |
| Divi's Lab. | 3685.00 | -212.55 | -5.45 | 6798.61 |
| Torrent Pharma. | 2579.15 | -36.95 | -1.41 | 6450.83 |
| Ipca Labs. | 960.40 | -16.65 | -1.70 | 5114.11 |
| Alembic Pharma | 759.95 | -0.45 | -0.06 | 5051.44 |
| Laurus Labs | 566.00 | -6.55 | -1.14 | 4768.72 |
| Abbott India | 17683.65 | -68.85 | -0.39 | 4310.02 |
| Gland Pharma | 2869.00 | -111.95 | -3.76 | 3462.88 |
| Glaxosmi. Pharma | 1545.55 | -9.50 | -0.61 | 3193.74 |
| Granules India | 283.20 | 3.05 | 1.09 | 3134.98 |
| Sanofi India | 6607.25 | -29.20 | -0.44 | 2956.60 |
| Ajanta Pharma | 1701.25 | -24.85 | -1.44 | 2718.59 |
Quick Links for Mesco Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
